Healthcare Magazine March 2016 | Page 86

PROBIOMED , S . A . DE C . V .
“ Our investments in R & D top every other company ’ s , as 20 to 23 percent of our revenue is earmarked for this purpose ,” the CEO explained .
Formula and procedure improvements
The most experimented biotech professionals and trainees enter PROBIOMED ’ s facilities every day with the same purpose : benefit patients on treatment for chronicdegenerative conditions
Technology in PROBIOMED is a resource to upgrade procedures leading to obtain and improve formulas . Biotech includes procedures of genetic engineering , molecular and cell biology , cell counting , particle segregation , particle measurement , and others , performed with specialized equipment .
“ We have worked thoroughly in Mexico and abroad with different institutions with the goal of developing our own tech resources , hence we
86 March 2016